Induced regulatory T cells in inhibitory microenvironments created by cancer.
about
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingImmune Evasion Strategies of GlioblastomaNovel technologies and emerging biomarkers for personalized cancer immunotherapyThe potential of tumor-derived exosomes for noninvasive cancer monitoringThe role of regulatory T cells in cancer immunologyBig opportunities for small molecules in immuno-oncology.Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms' Tumor 1 in Patients with Advanced Colorectal Cancer.Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironmentProgrammed death-1 checkpoint blockade in acute myeloid leukemia.Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancerClinical Impact of Regulatory T cells (Treg) in Cancer and HIV.Emerging Opportunities and Challenges in Cancer Immunotherapy.DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing.Restricting Glutamine or Glutamine-Dependent Purine and Pyrimidine Syntheses Promotes Human T Cells with High FOXP3 Expression and Regulatory Properties.Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(-) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans.The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells.Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.The Dual Role of Treg in Cancer.The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.Separation of plasma-derived exosomes into CD3(+) and CD3(-) fractions allows for association of immune cell and tumor cell markers with disease activity in HNSCC patients.Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.Determination of a CD4+CD25-FoxP3+ T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-γ.
P2860
Q26742012-F2ABB3C1-5C8D-4D6F-8317-E273CF73957BQ26765855-05B935BC-C4D0-4B65-8CAA-F957B96E5A06Q26770780-29BC27D9-7EBB-4D6B-974E-7F03FD22F69CQ26796396-E9BDC94C-BDBC-451A-B949-CEA1B047487CQ27006663-288A64F9-2370-47C1-8691-DF397E6A6DB7Q34487689-FA5C704D-C9D3-4BC2-86CE-421259CF8496Q36299565-AFA07B34-ED85-467C-82B0-9E6BA267677AQ36409532-C596995E-BDBE-41EB-BA95-0458B7E23FF6Q36542190-F03DFCB2-7E7E-489F-8F71-075284640D5CQ36572163-08B7AE75-B3C8-44DE-82ED-1F6528E06554Q36652124-555F088B-D4BF-4CCD-A55D-BDE92E093827Q37590247-3BC4E33F-4322-42AF-8C40-A73EE76652F8Q38266807-E077684B-D65F-4508-81E6-49120C0D6B2DQ38809772-7E332BD1-97A6-4A97-9974-057A06308137Q38928826-F9259810-97C1-4AAB-B60E-DA6E059ECBD6Q39289084-4E4ACA2A-DB66-47C6-B108-519413836C3FQ39378337-51F9E838-5C70-4A99-A62B-250A0D88FF25Q39561722-8AAB954D-F3CB-43F5-B286-07A77922084FQ41819129-264BB6B5-CE38-45FE-B361-95387A106988Q47146090-C978B3C9-3D56-4160-BF1A-F31D9022C8CDQ47755372-B439F62E-DC00-4D4B-9D2A-9B195D759BA5Q49322680-AD399922-8B86-4D20-9AFA-725421E60C99Q50044364-C04A8248-631E-4669-B2BF-74826212175BQ50065313-D25FCEEE-7116-42AA-82C3-F637C539A610Q50545420-2261CC8A-611A-4DEB-9CCA-64ECBCFC6136Q51079342-F280830A-C343-4E1A-B47E-1E92DC7FD0E5Q51516450-B306D5F5-EAF1-4E5E-A0C3-E8C6504DEC39
P2860
Induced regulatory T cells in inhibitory microenvironments created by cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Induced regulatory T cells in inhibitory microenvironments created by cancer.
@en
type
label
Induced regulatory T cells in inhibitory microenvironments created by cancer.
@en
prefLabel
Induced regulatory T cells in inhibitory microenvironments created by cancer.
@en
P2860
P1476
Induced regulatory T cells in inhibitory microenvironments created by cancer.
@en
P2093
Theresa L Whiteside
P2860
P304
P356
10.1517/14712598.2014.927432
P407
P577
2014-06-17T00:00:00Z